Full-Time

Director ECG Solutions

Updated on 9/3/2026

Baxter International

Baxter International

10,001+ employees

Global provider of medical care products

Compensation Overview

$208k - $286k/yr

+ Bonus + Commission + Long-term incentive

Nashville, TN, USA + 4 more

More locations: Dallas, TX, USA | Deerfield, IL, USA | Durham, NC, USA | Denver, CO, USA

Hybrid

Flexible workplace policy requires a minimum number of on-site days per week.

Bachelor's, Master's

Category
Sales & Account Management (1)
Required Skills
Microsoft Office
CRM

Get referred to Baxter International

See people who can refer or advise you

Requirements
  • A bachelor's degree is required.
  • A minimum of 5 years of people management experience in a sales or commercial leadership environment is required, including experience leading multi-role sales organizations such as hunters and farmers.
  • Progressive experience in healthcare sales, technical or solution-based selling, or enterprise commercial leadership is required.
  • Experience hiring, developing, coaching, and managing high-performing sales organizations is required.
  • Experience negotiating and approving complex healthcare commercial agreements, including Business Associate Agreements, Software-as-a-Service agreements, and End User License Agreements, is required.
  • Strong executive presence and exceptional written, verbal, interpersonal, and presentation communication skills are required.
  • Expertise in revenue forecasting, pipeline management, and customer relationship management hygiene is required.
  • Experience with executive-level negotiations and complex deal structures is required.
  • Proficiency in Microsoft Office applications is required.
Responsibilities
  • Provide strategic and operational leadership for a multidisciplinary commercial organization focused on cardiology hardware, electrocardiogram management solutions, cardiology portfolio offerings, and enterprise connectivity offerings.
  • Drive revenue growth, define and execute go-to-market strategies, and lead national sales and technical teams.
  • Ensure alignment across cross-functional stakeholders and own quota, pricing, and contractual decisions.
  • Lead hiring, onboarding, coaching, performance management, corrective actions, and terminations for direct reports.
  • Develop talent through ongoing assessment of skills, performance, and development needs.
  • Establish and monitor individual and team performance metrics, dashboards, and accountability frameworks.
  • Travel extensively with team members to evaluate selling effectiveness, customer engagement quality, and market dynamics.
  • Define and execute commercial strategies for cardiology and connectivity solutions aligned with corporate objectives.
  • Lead quarterly pipeline health reviews, revenue quality assessments, and quarterly actuals and performance analyses.
  • Define and lead growth opportunities for ACM using relationships and the network of Cardiology Sales Executives.
  • Provide regional and national sales support for complex, strategic, or executive-level customer engagements as needed.
  • Serve as an executive-level commercial leader in key customer, original equipment manufacturer partner, and Integrated Delivery Network relationships.
  • Lead Integrated Delivery Network pricing strategy development and contract negotiation efforts for Cardio Server.
  • Serve as the final approver for Cardio Server pricing and commercial quotes.
  • Negotiate Business Associate Agreements, End User License Agreements, Software-as-a-Service agreements, and other legal documents as required for Cardio Server.
  • Ensure pricing, contracting, and commercial practices comply with internal policy and external regulatory requirements.
  • Partner with Downstream Marketing and cross-functional stakeholders on value messaging, campaigns, partner strategy, and go-to-market execution.
  • Collaborate with Legal, Finance, Operations, and Professional Services to ensure alignment on strategy, processes, and execution across the customer lifecycle.
Desired Qualifications
  • Knowledge of clinical workflows for cardiology and information technology is a plus.
  • Familiarity with Front Line Care sales processes and product portfolios is preferred.
  • A master's degree is preferred.

Baxter International produces medical products and equipment used in hospitals and blood banks. Its innovations include sterile IV solutions and blood-storage technologies, such as the Transfuso-Vac that extended blood shelf life and a plastic blood storage container. The company differentiates itself through a long history of sterile manufacturing, blood-storage breakthroughs, and strategic acquisitions that expand its product portfolio and scale. Its goal is to provide reliable, safe medical products that support patient care and hospital operations worldwide.

Company Size

10,001+

Company Stage

IPO

Headquarters

Deerfield, Illinois

Founded

1931

Get referred to Baxter International

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 organic growth reached 5%, with every segment expanding in U.S. and international markets.
  • Medical Products and Therapies generated $2.1 billion in Q2, driven by IV Solutions.
  • New CFO John Rogers starts October 1, supporting stabilization and balance-sheet repair.

What critics are saying

  • August 2026 recalls for saline, dextrose, and citrate expose manufacturing quality failures.
  • ShinyHunters' August 2026 theft claim threatens customer trust and regulatory scrutiny across third-party systems.
  • Repeated contamination incidents can trigger contract losses, margin pressure, and management turnover by 2027.

What makes Baxter International unique

  • Baxter's IV solutions, infusion systems, and hospital consumables remain deeply embedded in care delivery.
  • Q2 2026 sales rose 5%; Advanced Surgery grew 12%, showing portfolio breadth.
  • The Novum IQ hold highlights scale: Baxter still sells through entrenched hospital installed bases.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Parental Leave

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Commuter Benefits

Mental Health Support

Growth & Insights and Company News

Headcount

6 month growth

13%

1 year growth

13%

2 year growth

13%
McDowell News
Sep 4th, 2026
Baxter International issues recall of IV solutions made at McDowell County plant.

Baxter International issues recall of IV solutions made at McDowell County plant. Baxter International has issued two recalls of intravenous products which were manufactured at the plant in the North Cove community of McDowell County. Get the latest local business news delivered FREE to your inbox weekly. Staff Writer

FOX8 WGHP
Sep 4th, 2026
Fiberglass found in IV solution made in North Carolina: FDA.

Fiberglass found in IV solution made in North Carolina: FDA. Posted: Sep 4, 2026 / 08:09 AM EDT Updated: Sep 4, 2026 / 08:09 AM EDT MCDOWELL COUNTY, N.C. (WSPA) - A medical equipment company recalled two lots of IV solution last week after potential fiberglass contamination was identified in products manufactured in western North Carolina. Baxter Healthcare issued a voluntary recall on Aug. 25 for two lots of 0.9% Sodium Chloride Injection. According to the FDA, particulate matter in injectable products can cause blood clotting, which can lead to permanent organ damage or death. The product was manufactured at the company's North Cove facility outside of Marion. The solution was distributed to providers from July 31 through Aug. 3, 2026, in the Carolinas and Georgia, as well as Florida, Illinois, Indiana, Louisiana, Maryland, New Jersey, Nevada, New York, Ohio, Texas, and Virginia. The product is packaged in 500 mL VIAFLEX plastic containers, with 24 units in each case. In a statement shared with 7NEWS, Baxter said it initiated the recall in coordination with the FDA after identifying potential particulate matter in the affected solutions. Top headlines on MyFOX8.com. As of Sept. 1, the company said it had not received any reports of adverse events associated with the recalled lots. Health care providers should discontinue use of and return all affected units according to their facility's recall procedures. Health care providers with questions about the recall can contact the Baxter Healthcare Center for Service at (888) 229-0001 between 7 a.m. and 6 p.m. CDT, Monday through Friday.

Morgan & Morgan
Sep 2nd, 2026
The week in recalls: week of september 4th, 2026.

The week in recalls: week of september 4th, 2026. Injured? Morgan & Morgan, PA can help. The following product recalls have been announced this week - make sure you're in the know. Automated Impella heart pump Controllers. Abiomed has recalled all Automated Impella Controllers due to purge cassette recognition failures that can interrupt treatment. The issue has been associated with 37 serious injuries and three deaths. Baxter Sodium Chloride Injection bags. Baxter has recalled certain 0.9% Sodium Chloride Injection bags due to potential fiberglass contamination. If administered, the particles could pose serious health risks to patients. Britax b-safe and endeavours infant car seats. Britax has recalled more than 114,000 infant car seats because a screw in the carrying handle can loosen, potentially causing the handle to partially detach and creating a fall and injury hazard. Zicam Cold Remedy Medicated Nasal Swabs. Certain Zicam Cold Remedy Medicated Nasal Swabs have been recalled due to a potential health risk. Manufacturing inspections identified microbiological testing issues. SHEIN Spiral Toys. SHEIN Distribution Corporation has recalled its Spiral Toys due to a choking hazard and a risk of serious injury or death. The toys violate the federal small-ball ban for products intended for children under three. XO Poppy Power Trip Magnetic Wireless Power Banks. Truststone Group has recalled its XO Poppy Power Trip Magnetic Wireless Power Banks due to fire and burn hazards. The lithium-ion batteries can overheat and ignite. Mistolin and Lestoil multi-purpose cleaners. Clorox Puerto Rico has recalled about 6.3 million scented Mistolin and Lestoil cleaners because they may contain bacteria, including Pseudomonas aeruginosa, which can cause serious infections in people with weakened immune systems. Alanca 6-Drawer Dressers. Nanjing Wu Hai Smart Home Appliance Store has recalled its Alanca 6-Drawer Dressers due to tip-over and entrapment hazards and a risk of serious injury or death. The dressers violate the mandatory standard for clothing storage units and can tip over if not anchored to the wall. Gizoon Six-Drawer Double Dressers. Gizoon Direct has recalled its Six-Drawer Double Dressers due to tip-over and entrapment hazards and a risk of serious injury or death. The dressers violate the mandatory standard for clothing storage units. Skip Hop Baby Sesame Street Elmo Silicone Teethers. Skip Hop has recalled its Baby Sesame Street Elmo Silicone Teethers due to a choking hazard and a risk of serious injury or death. The black eyes can detach if the teether is frozen. Amana through-the-wall air conditioners and heat pumps. Daikin Comfort Technologies Manufacturing has recalled certain Amana through-the-wall air conditioners and heat pumps due to a fire hazard and a risk of serious injury. The snubber circuit can emit flames if it shorts. Branch Ergonomic Chairs. Branch has recalled its Ergonomic Chairs due to a fall hazard. The backrest can detach from the chair during use. GIHNJSI Squeezy Dumplings Toys. GIHNJSI Squeezy Dumplings Toys have been recalled due to serious ingestion, choking, and intestinal obstruction hazards. The squeezy toys contain water beads that can be ingested by a child. Mountain bicycles with ONOFF S9 Carbon MTB Handlebars. MONDRAKER USA has recalled certain mountain bicycles equipped with ONOFF S9 Carbon MTB Handlebars due to a fall hazard and a risk of serious injury or death. The affected handlebars may crack or fracture during use, which can lead to loss of control. Cambridge Audio Yoyo (M) Portable Bluetooth Speakers. Audio Partnership has recalled its Cambridge Audio Yoyo (M) Portable Bluetooth Speakers due to a fire hazard. The lithium-ion batteries can overheat and ignite. Loyoda adult portable bed rails. Adult portable bed rails sold by Loyoda Direct and Loyoda have been recalled due to entrapment and asphyxiation hazards and a risk of serious injury or death. Users can become entrapped within the bed rail or between the bed rail and the side of the mattress; the bed rails do not meet retention strap requirements; the bed rails' push pins and push pin holes are incorrectly sized; and the bed rails do not bear the required hazard warning labels. Rainbow Mystery Squishy Bun Toys. OKK Trading has recalled its Rainbow Mystery Squishy Bun Toys due to a water bead ingestion hazard and a risk of serious injury or death. The toys contain water beads that can be ingested by a child. 2024-2026 ford Mustang vehicles. Ford has recalled nearly 149,000 2024-2026 Mustang vehicles due to an increased risk of a crash. Engine-compartment wiring harness ground connections may fracture, potentially causing a loss of drive power or disabling the headlights, windshield washer, air conditioning, or engine cooling fan. If these recalled products have caused you or a loved one injury, you may be entitled to compensation. Take action and contact Morgan & Morgan today for a free, no-obligation case evaluation. Disclaimer This website is meant for general information and not legal advice.

TEISS
Aug 31st, 2026
ShinyHunters claims theft of more than 7.1 million Baxter International records.

ShinyHunters claims theft of more than 7.1 million Baxter International records. Medical technology firm Baxter International disclosed a major cybersecurity incident after the ShinyHunters hacking group said that it had infiltrated the company's internal systems and exfiltrated more than 7.1 million records. Headquartered in Deerfield, Illinois, Baxter International is a global American medical technology company that develops and manufactures products for treating acute and chronic medical conditions. Its portfolio includes IV solutions, infusion pumps, clinical nutrition therapies, surgical sealants, hospital beds, patient monitoring systems, and operating-room integration equipment. Baxter also provides specialty injectable medicines, inhaled anesthetics, and drug-compounding services. In a data security notification posted on its website, Baxter International revealed that it had identified unauthorised access involving certain third-party applications. The company immediately launched an investigation, with assistance from external cyber security experts, to determine the scope and impact of the incident. It also took steps to secure the affected systems and notified relevant law enforcement authorities about the incident. While the investigation remains ongoing, Baxter International said there has been no impact on its manufacturing operations, customer operations, patient services, or overall business continuity. The company continues to operate normally. "Teiss has no evidence that this activity affected Baxter products, connected solutions or technologies used by customers to deliver patient care. "Healthcare providers and customers can continue using Baxter products and connected solutions as intended," the medical device manufacturer said. The company said it is continuing to assess what information may have been accessed or acquired. The investigation is still ongoing, and Baxter International will share further updates as more details are confirmed. "At this time, we do not expect a material impact on financials or results of operations as a result of this incident," Baxter International added. The ShinyHunters ransomware group claimed responsibility for the cyber attack on Baxter International listing the company as a victim on its data leak site.The group claimed to have obtained 7.1 million records from the company and threatened to release it publicly. Following unsuccessful ransom negotiations, on August 19, the hacker group released the stolen data.

WLNS
Aug 28th, 2026
2 drugs recalled over potential fiberglass, steel presence.

2 drugs recalled over potential fiberglass, steel presence. by: Zach Kaplan Posted: Aug 27, 2026 / 08:35 PM EDT Updated: Aug 27, 2026 / 08:50 PM EDT (NewsNation) - Baxter International voluntarily recalled two drugs this week over the potential presence of particulate matter, including steel and fiberglass. The Food and Drug Administration said Aug. 25 that the large healthcare company voluntarily recalled a single lot of its 70% Dextrose Injection over the potential presence of steel particles. The product was distributed nationwide to healthcare providers from July 25, 2026, through July 28, 2026. The injection is used to "provide your body with extra water and carbohydrates," according to the Mayo Clinic. "It is used when a patient is not able to drink enough liquids or when additional fluids are needed." The FDA warned that the presence of steel particles in the solution can lead to potentially life-threatening health consequences. The recall is most likely to impact patients who get IV nutrition at home, Medical Daily reported. That same day, the FDA announced a second voluntary recall for Anticoagulant Sodium Citrate Solution because it may contain fiberglass. The product was distributed from July 2, 2026, through July 11, 2026, to one customer in the U.S. The extent of harm that particulate matter can cause in the sodium citrate solution depends on "the size, number, morphology, and composition of the foreign material," the FDA said. The solution slows down blood clotting during apheresis procedures, the agency previously confirmed. Both products were packaged in VIAFLEX plastic containers. As of this week, the FDA said there have been no reports of adverse effects from these products. For questions, consumers can call the company at 888-229-0001 during standard business hours. "Baxter is contacting customers by email with instructions on how to identify and return the impacted product(s)," the FDA added. This follows another voluntary Baxter recall last month for one lot of its Cefazolin in Dextrose Injection after cardboard was found in the solution, the FDA said.